Loading…

Establishing hospital admission criteria of pediatric Henoch–Schonlein purpura

The current study aimed to define evidence-based admission criteria of pediatric Henoch–Schonlein purpura (HSP). In addition, we aimed to better characterize epidemiological and clinical features of pediatric HSP in Israel. We performed a retrospective cohort study of all children with HSP admitted...

Full description

Saved in:
Bibliographic Details
Published in:Rheumatology international 2014-11, Vol.34 (11), p.1497-1503
Main Authors: Masarweh, Kamal, Horovitz, Yoseph, Avital, Avi, Spiegel, Ronen
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The current study aimed to define evidence-based admission criteria of pediatric Henoch–Schonlein purpura (HSP). In addition, we aimed to better characterize epidemiological and clinical features of pediatric HSP in Israel. We performed a retrospective cohort study of all children with HSP admitted during a 15 years period to a single pediatric department. We strictly collected the clinical data of all HSP cases. Each case was categorized as either “necessary admission” or “unnecessary admission.” We compared the two groups, using initially Chi square ( χ 2 ) and student “ t ” tests, and thereafter, we employed logistic stepwise regression analysis. One hundred and sixty-three children with HSP were included. A set of six clinical criteria of which the presence of minimum one predicts the need for hospitalization were identified including: orchitis, moderate or severe abdominal pain, arthritis involving more than two joints, proteinuria, clear evidence of gastrointestinal bleeding, and inability to ambulate. In conclusion, we suggest a predictive model for the admission of pediatric patients with acute HSP. The implementation of this model can significantly reduce unnecessary admissions.
ISSN:0172-8172
1437-160X
DOI:10.1007/s00296-014-2971-9